Reproducible, accurate and specific diagnostic test methods will enable a coordinated global approach which targets existing treatments effectively and supports the rollout of emerging antibiotics and other antimicrobial drugs.
AntiMicroResist will aid clinicians by developing the measurement needed to reliably evaluate new and existing clinical test methods used in the detection and monitoring of antimicrobial resistance, including reference materials for calibrating instruments and test systems. In addition, validated methods will also enable laboratories to benchmark their procedures, ensuring high accuracy, comparable measurements across Europe. Achieving these objectives will increase the efficacy of clinical testing, allowing clinicians to better target existing and novel treatments and mitigating the key driver of antimicrobial resistance.
We will work with partners, hospitals and key stakeholder charities to develop the measurement science needed to manage antimicrobial resistance.